HDL PARTICLE CONCENTRATION IS NOT ASSOCIATED WITH RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS FOLLOWING ACUTE CORONARY SYNDROMES

被引：0
|
作者：
Salahuddin, Taufiq
Kittleson, John
Tardif, Jean Claude
Shah, Prediman
Olsson, Anders
Nicholls, Stephen
McMurray, John J. V.
Leitersdorf, Eran
Leiter, Lawrence
Barter, Philip
Ballantyne, Christie
Schwartz, Gregory
机构：
[1] Denver VA Med Ctr, Denver, CO USA
[2] Univ Colorado, Sch Med, Aurora, CO USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(18)32312-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1771
引用
收藏
页码：1771 / 1771
页数：1
相关论文
共 50 条
  • [21] Association of an HDL Proteomic Score With the Presence of Coronary Atherosclerosis and Future Major Adverse Cardiovascular Events
    Natarajan, Pradeep
    Lyass, Asya
    Li, Yiwei
    Ibrahim, Nasrien E.
    Mukai, Renata
    McCarthy, Cian P.
    Massaro, Joseph M.
    D'Agostino, Ralph B.
    Gaggin, Hanna K.
    Januzzi, James L.
    [J]. CIRCULATION, 2018, 138
  • [22] Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation
    Schmidt, Morten
    Johansen, Martin B.
    Maeng, Michael
    Kaltoft, Anne
    Jensen, Lisette O.
    Tilsted, Hans-Henrik
    Botker, Hans E.
    Baron, John A.
    Sorensen, Henrik Toft
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (01) : 161 - 170
  • [23] Concomitant Clopidogrel and Statin Use and Risk of Major Adverse Cardiovascular Events Following Coronary Stent Implantation
    Schmidt, Morten
    Johansen, Martin B.
    Maeng, Michael
    Kaltoft, Anne
    Jensen, Lisette O.
    Tilsted, Hans-Henrik
    Botker, Hans E.
    Baron, John A.
    Sorensen, Henrik T.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B15 - B15
  • [24] Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes
    Moriarty, Patrick M.
    Steg, Philippe Gabriel
    McGinniss, Jennifer
    Zeiher, Andreas M.
    White, Harvey D.
    Manvelian, Garen
    Pordy, Robert
    Loy, Megan
    Jukema, J. Wouter
    Harrington, Robert A.
    V. Gray, Jessica
    Gorby, Lauryn K.
    Goodman, Shaun G.
    Diaz, Rafael
    Bittner, Vera A.
    Bhatt, Deepak L.
    Szarek, Michael
    Schwartz, Gregory G.
    ODYSSEY OUTCOMES Investigators
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (05) : 747 - 756
  • [25] Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes
    Gaoqiang Xie
    Yihong Sun
    Phyo Kyaw Myint
    Anushka Patel
    Xingzi Yang
    Min Li
    Xian Li
    Tao Wu
    Shenshen Li
    Runlin Gao
    Yangfeng Wu
    [J]. Lipids in Health and Disease, 16
  • [26] Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes
    Xie, Gaoqiang
    Sun, Yihong
    Myint, Phyo Kyaw
    Patel, Anushka
    Yang, Xingzi
    Li, Min
    Li, Xian
    Wu, Tao
    Li, Shenshen
    Gao, Runlin
    Wu, Yangfeng
    [J]. LIPIDS IN HEALTH AND DISEASE, 2017, 16
  • [27] Inflammation during acute coronary syndromes - Risk of cardiovascular events and bleeding
    Nanchen, David
    Klingenberg, Roland
    Gencer, Baris
    Raber, Lorenz
    Carballo, David
    von Eckardstein, Arnold
    Windecker, Stephan
    Rodondi, Nicolas
    Luscher, Thomas F.
    Mach, Francois
    Muller, Olivier
    Matter, Christian M.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 287 : 13 - 18
  • [28] Effects of thyroid hormones on major cardiovascular risk in acute coronary syndromes
    A Bayrak
    A Bayır
    K Uçar Karabulut
    [J]. Critical Care, 15 (Suppl 1):
  • [29] Triglycerides-to-HDL-cholesterol ratio predicts atherosclerosis severity and major adverse cardiovascular events after acute coronary syndrome
    Almeida-Gutierrez, E.
    Cruz-Madrigal, K. M.
    Borrayo-Sanchez, G.
    Madrid-Miller, M. A.
    Garcia-Mendez, R. C.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 923 - 924
  • [30] Thiazolidinedione treatment is not associated with an increased risk of major adverse cardiovascular events
    Bilik, Dorian
    McEwen, Laura N.
    Selby, Joe V.
    Marrero, David G.
    Brown, Arleen F.
    Herman, William H.
    [J]. DIABETES, 2008, 57 : A85 - A85
12345